Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "PLI"

4290 News Found

HCG launches breast Cancer Care Clinic in Bengaluru
Healthcare | June 23, 2026

HCG launches breast Cancer Care Clinic in Bengaluru

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted


QMS Medical targets Rs. 500 crore revenue by FY29
Healthcare | June 23, 2026

QMS Medical targets Rs. 500 crore revenue by FY29

The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26


KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
Hospitals | June 23, 2026

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman


BioMed X and Biogen launch global neuroimmunology research challenge
R&D | June 23, 2026

BioMed X and Biogen launch global neuroimmunology research challenge

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


FDA fast-tracks Roche cancer drug filing after landmark trial shows 50% recurrence reduction
Drug Approval | June 23, 2026

FDA fast-tracks Roche cancer drug filing after landmark trial shows 50% recurrence reduction

The FDA has granted Priority Review, setting a target decision date of 9 October 2026, potentially accelerating access to a new treatment option for a subset of patients with high-risk colon cancer characterized


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
Biopharma | June 22, 2026

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges


BPL Medical honours strategic partners with Pinnacle Awards 2026
Medical Device | June 22, 2026

BPL Medical honours strategic partners with Pinnacle Awards 2026

The company hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, inaugurated in 2024